Title : HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy.

Pub. Date : 2012 Jan 12

PMID : 22240029






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy. Epirubicin erb-b2 receptor tyrosine kinase 2 Homo sapiens